| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,593 |
5,359 |
$2.11M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,604 |
5,308 |
$1.46M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,147 |
4,380 |
$840K |
| 80053 |
Comprehensive metabolic panel |
11,907 |
9,836 |
$607K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,407 |
1,253 |
$576K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,381 |
1,210 |
$402K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,751 |
2,487 |
$392K |
| 87631 |
|
5,119 |
3,858 |
$373K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,661 |
9,231 |
$358K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,420 |
1,685 |
$325K |
| 36415 |
Collection of venous blood by venipuncture |
21,202 |
15,953 |
$311K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,394 |
1,972 |
$289K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,337 |
1,256 |
$283K |
| 71045 |
Radiologic examination, chest; single view |
4,335 |
3,186 |
$272K |
| J3490 |
Unclassified drugs |
6,011 |
2,472 |
$258K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
630 |
479 |
$257K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,443 |
4,632 |
$248K |
| 83605 |
|
4,976 |
3,931 |
$207K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,657 |
1,186 |
$196K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
907 |
813 |
$188K |
| 84484 |
|
5,120 |
2,836 |
$186K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,167 |
3,324 |
$185K |
| 71046 |
Radiologic examination, chest; 2 views |
2,040 |
1,877 |
$177K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,346 |
1,416 |
$161K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,236 |
2,951 |
$138K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,802 |
1,279 |
$137K |
| 81001 |
|
5,441 |
4,230 |
$137K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,423 |
1,233 |
$127K |
| 85027 |
|
3,560 |
2,985 |
$126K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,763 |
1,661 |
$125K |
| 80061 |
Lipid panel |
2,270 |
2,097 |
$122K |
| 64483 |
|
162 |
99 |
$103K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
127 |
100 |
$98K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,470 |
1,105 |
$95K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,820 |
1,795 |
$93K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,281 |
2,137 |
$84K |
| G0378 |
Hospital observation service, per hour |
419 |
305 |
$84K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,067 |
843 |
$81K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,674 |
1,533 |
$75K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,844 |
1,617 |
$73K |
| A9270 |
Non-covered item or service |
26,926 |
6,258 |
$72K |
| 96376 |
|
748 |
403 |
$71K |
| 83735 |
|
2,002 |
1,562 |
$68K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
105 |
99 |
$67K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
859 |
791 |
$65K |
| 83690 |
|
1,809 |
1,465 |
$65K |
| 93017 |
|
197 |
173 |
$61K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
518 |
470 |
$59K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
105 |
87 |
$58K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,822 |
875 |
$55K |
| 87040 |
|
821 |
682 |
$55K |
| 71250 |
|
172 |
159 |
$53K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
468 |
343 |
$50K |
| 80305 |
|
730 |
609 |
$49K |
| 84703 |
|
951 |
787 |
$49K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
216 |
212 |
$44K |
| 73030 |
|
427 |
371 |
$42K |
| 87081 |
|
1,318 |
1,204 |
$41K |
| 74178 |
|
99 |
85 |
$41K |
| 73630 |
|
361 |
299 |
$38K |
| 73610 |
|
382 |
338 |
$38K |
| 74019 |
|
232 |
222 |
$37K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,581 |
1,074 |
$37K |
| 87186 |
|
975 |
863 |
$36K |
| 82948 |
|
835 |
382 |
$36K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
539 |
400 |
$35K |
| 87077 |
|
1,201 |
1,059 |
$35K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,696 |
1,062 |
$35K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
227 |
160 |
$34K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
806 |
202 |
$34K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
742 |
258 |
$33K |
| 85610 |
|
1,248 |
812 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
149 |
138 |
$32K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,425 |
1,102 |
$31K |
| 84439 |
|
678 |
635 |
$31K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,945 |
1,333 |
$30K |
| 97162 |
|
466 |
409 |
$29K |
| 72100 |
|
226 |
219 |
$29K |
| J2400 |
Injection, chloroprocaine hydrochloride, per 30 ml |
127 |
99 |
$27K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
610 |
555 |
$27K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,045 |
436 |
$22K |
| 82607 |
|
325 |
293 |
$22K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
937 |
683 |
$22K |
| 83880 |
|
416 |
348 |
$21K |
| 73560 |
|
194 |
162 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
313 |
286 |
$20K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
83 |
81 |
$20K |
| J2704 |
Injection, propofol, 10 mg |
912 |
582 |
$20K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
395 |
151 |
$19K |
| 85379 |
|
485 |
395 |
$18K |
| 87070 |
|
376 |
323 |
$17K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
427 |
267 |
$17K |
| 73110 |
|
129 |
102 |
$15K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
276 |
182 |
$14K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
72 |
67 |
$11K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
996 |
873 |
$11K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
576 |
435 |
$9K |
| 82805 |
|
158 |
120 |
$7K |
| 82150 |
|
91 |
75 |
$7K |
| 80050 |
General health panel |
48 |
46 |
$7K |
| 73130 |
|
69 |
63 |
$7K |
| 36600 |
|
164 |
120 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
67 |
59 |
$6K |
| T1015 |
Clinic visit/encounter, all-inclusive |
60 |
51 |
$6K |
| 94060 |
|
80 |
71 |
$6K |
| 87205 |
|
133 |
119 |
$5K |
| 87807 |
|
58 |
52 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
187 |
128 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
53 |
46 |
$5K |
| 0012A |
|
200 |
167 |
$4K |
| 73502 |
|
28 |
27 |
$4K |
| 0011A |
|
264 |
239 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
12 |
$3K |
| 87430 |
|
33 |
30 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
15 |
15 |
$3K |
| 94727 |
|
51 |
46 |
$3K |
| 82043 |
|
60 |
53 |
$3K |
| 86769 |
|
49 |
25 |
$2K |
| 73521 |
|
13 |
13 |
$2K |
| 94729 |
|
52 |
47 |
$2K |
| 86318 |
|
25 |
24 |
$2K |
| 83540 |
|
51 |
50 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
18 |
13 |
$2K |
| 94664 |
|
24 |
14 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
15 |
12 |
$2K |
| 82728 |
|
42 |
39 |
$2K |
| 0013A |
|
62 |
62 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
33 |
14 |
$1K |
| 85652 |
|
32 |
26 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
61 |
46 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
15 |
13 |
$1K |
| 74022 |
|
15 |
15 |
$1K |
| 94200 |
|
53 |
48 |
$956.74 |
| 94150 |
|
53 |
48 |
$753.03 |
| 84145 |
|
14 |
12 |
$698.43 |
| 82800 |
|
15 |
12 |
$698.31 |
| 0001A |
|
35 |
35 |
$591.55 |
| 0072A |
|
20 |
20 |
$490.40 |
| 82550 |
|
22 |
14 |
$369.34 |
| 0071A |
|
14 |
13 |
$325.60 |
| 86901 |
|
15 |
13 |
$122.18 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
83 |
54 |
$94.39 |
| 91301 |
|
662 |
513 |
$16.60 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
44 |
41 |
$4.68 |
| 91300 |
|
96 |
94 |
$0.43 |
| 91307 |
|
56 |
51 |
$0.00 |